Biotransformation by beta glucosidase enhances anti inflammatory metabolites in licorice using untargeted metabolomics

Abstract

Licorice (Glycyrrhiza uralensis) has traditionally been used as a food-derived herbal remedy for inflammation; however, the anti-inflammatory potential of its fermented extract in skin health is still unclear. This study investigated fermented licorice extract (FLE) for its effects against glyoxal-derived advanced glycation end products (GO-AGEs) and ultraviolet B (UVB)-induced skin inflammation in HaCaT keratinocytes. At 10 mu g/mL, FLE reduced IL-6 levels by 46% and TNF-alpha levels by 52%, and significantly lowered PGE2 levels. Mechanistic evaluation showed that FLE suppressed inflammatory signaling pathways, particularly nuclear factor-kappa B (NF-kappa B) and mitogen-activated protein kinases (MAPKs). Untargeted metabolomics identified fermentation-enhanced bioactive metabolites, including glycyrrhetic acid-3-O-glucuronide, 18 beta-glycyrrhetic acid, 24-hydroxyglycyrrhetic acid, and isoliquiritigenin, which correlated with anti-inflammatory activity. Notably, 18 beta-glycyrrhetic acid and isoliquiritigenin exhibited potent antiglycation effects and cytokine suppression. These results suggest that fermentation enhances the bioactive profile of licorice, supporting its potential as a functional ingredient for managing skin inflammation from GO-AGEs and UVB exposure.